The following 27 images provide visual information about the product associated with Hulio NDC 83257-019 by Biocon Biologics Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1. Study RA-III ACR 20 Responses over 52 Weeks - image 01
Figure 2. ASAS 20 Response By Visit, Study AS-I - image 02
Hulio Pen Logo - image 03
Pen Instructions for Use Figure A - image 04
Pen Instructions for Use Figure B - image 05
Pen Instructions for Use Figure C - image 06
Pen Instructions for Use Figure D - image 07
Pen Instructions for Use Figure E - image 08
Pen Instructions for Use Figure F - image 09
Pen Instructions for Use Figure G - image 10
Pen Instructions for Use Figure H - image 11
Pen Instructions for Use Figure I - image 12
Pen Instructions for Use Figure J - image 13
Hulio Syringe Logo - image 14
Instructions for Use Figure A - image 15
Instructions for Use Figure B - image 16
Instructions for Use Figure C - image 17
Instructions for Use Figure D - image 18
Instructions for Use Figure E - image 19
Instructions for Use Figure F - image 20
Instructions for Use Figure G - image 21
Instructions for Use Figure H - image 22
Instructions for Use Figure I - image 23
HULIO Prefilled Syringe Carton - 20 mg/0.4 mL - image 24
HULIO Prefilled Syringe Carton - 40 mg/0.8 mL - image 25
HULIO Prefilled Pen - 40 mg/0.8 mL - image 26
Figure 3: Kaplan-Meier Curves Summarizing Time to Treatment Failure on or after Week 6 (Study UV I) or Week 2 (Study UV II) - image 27